Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data
暂无分享,去创建一个
John M. Miller | P. Gething | K. Battle | E. Cameron | S. Sovannaroth | T. Bousema | G. Stresman | J. Stevenson | C. Drakeley | N. Sepúlveda | F. Nosten | U. d’Alessandro | A. Siqueira | M. Lacerda | M. Mayxay | S. Yeung | D. Parker | A. Dondorp | L. von Seidlein | Koukeo Phommasone | K. Fornace | T. Eisele | J. Mosha | J. Landier | J. Achan | L. Grignard | F. Tadesse | F. Espino | A. Young | D. Bridges | G. Delmas | Joanna Gallay | Emilie Pothin | J. Lemoine | A. Quispe | M. Chang | Julia Mwesigwa | K. Hamre | M. L. Macalinao | Pauline J Lorenzo | E. Pothin
[1] Anna M. Winters,et al. Malaria case management in Zambia: A cross-sectional health facility survey. , 2019, Acta tropica.
[2] Su Yun Kang,et al. Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study , 2019, The Lancet.
[3] R. Pullan,et al. Malaria Burden through Routine Reporting: Relationship between Incidence and Test Positivity Rates. , 2019, The American journal of tropical medicine and hygiene.
[4] P. Newton,et al. Treatment-seeking behaviour for febrile illnesses and its implications for malaria control and elimination in Savannakhet Province, Lao PDR (Laos): a mixed method study , 2019, BMC Health Services Research.
[5] O. Faye,et al. Spatiotemporal characterisation and risk factor analysis of malaria outbreak in Cabo Verde in 2017 , 2019, Tropical Medicine and Health.
[6] Georgina S. Humphreys,et al. Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis , 2019, The Lancet. Infectious diseases.
[7] P. Rosenthal,et al. Persistent Parasitemia Despite Dramatic Reduction in Malaria Incidence After 3 Rounds of Indoor Residual Spraying in Tororo, Uganda , 2018, The Journal of infectious diseases.
[8] T. Bousema,et al. Mass Drug Administration With Dihydroartemisinin-piperaquine and Malaria Transmission Dynamics in The Gambia: A Prospective Cohort Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[9] P. Gething,et al. malariaAtlas: an R interface to global malariometric data hosted by the Malaria Atlas Project , 2018, Malaria Journal.
[10] Hannah C. Slater,et al. The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low-Endemic Setting in Ethiopia , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Saorin Kim,et al. Closing in on the Reservoir: Proactive Case Detection in High-Risk Groups as a Strategy to Detect Plasmodium falciparum Asymptomatic Carriers in Cambodia , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] Joel Hellewell,et al. Examining the human infectious reservoir for Plasmodium falciparum malaria in areas of differing transmission intensity , 2017, Nature Communications.
[13] Samir Bhatt,et al. Quantifying the contribution of Plasmodium falciparum malaria to febrile illness amongst African children , 2017, eLife.
[14] David L. Smith,et al. Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure , 2017, bioRxiv.
[15] L. Robinson,et al. The complex relationship of exposure to new Plasmodium infections and incidence of clinical malaria in Papua New Guinea , 2017, eLife.
[16] John M. Miller,et al. Effectiveness of reactive case detection for malaria elimination in three archetypical transmission settings: a modelling study , 2017, Malaria Journal.
[17] K. Marsh,et al. Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance , 2017, Journal of leukocyte biology.
[18] M. Tanner,et al. Defining the next generation of Plasmodium vivax diagnostic tests for control and elimination: Target product profiles , 2017, PLoS neglected tropical diseases.
[19] Ruben O. Conner,et al. Short-term Impact of Mass Drug Administration With Dihydroartemisinin Plus Piperaquine on Malaria in Southern Province Zambia: A Cluster-Randomized Controlled Trial , 2016, The Journal of infectious diseases.
[20] O. Doumbo,et al. The Impact of Hotspot-Targeted Interventions on Malaria Transmission in Rachuonyo South District in the Western Kenyan Highlands: A Cluster-Randomized Controlled Trial , 2016, PLoS medicine.
[21] F. Nosten,et al. Numerical Distributions of Parasite Densities During Asymptomatic Malaria , 2015, The Journal of infectious diseases.
[22] Hannah C. Slater,et al. Comparison of diagnostics for the detection of asymptomatic Plasmodium falciparum infections to inform control and elimination strategies , 2015, Nature.
[23] Amanda Ross,et al. Assessing the impact of next-generation rapid diagnostic tests on Plasmodium falciparum malaria elimination strategies , 2015, Nature.
[24] C. Menéndez,et al. Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy. , 2015, The New England journal of medicine.
[25] Samir Bhatt,et al. Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malaria , 2015, Nature Communications.
[26] Nicholas P. J. Day,et al. High-Throughput Ultrasensitive Molecular Techniques for Quantifying Low-Density Malaria Parasitemias , 2014, Journal of Clinical Microbiology.
[27] Thomas A. Smith,et al. Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children , 2012, Proceedings of the National Academy of Sciences.
[28] Teun Bousema,et al. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control , 2012, Nature Communications.
[29] Simon I. Hay,et al. Stable and Unstable Malaria Hotspots in Longitudinal Cohort Studies in Kenya , 2010, PLoS medicine.
[30] M. Tanner,et al. Age-Patterns of Malaria Vary with Severity, Transmission Intensity and Seasonality in Sub-Saharan Africa: A Systematic Review and Pooled Analysis , 2010, PloS one.
[31] D. Mtasiwa,et al. Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with Fever , 2009, PLoS medicine.
[32] R. Snow,et al. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya , 2008, The Lancet.
[33] David L Smith,et al. Measuring malaria endemicity from intense to interrupted transmission , 2008, The Lancet. Infectious diseases.
[34] David L. Smith,et al. Standardizing estimates of the Plasmodium falciparum parasite rate , 2007, Malaria Journal.